NASDAQ:PACB

Pacific Biosciences Of California Stock News

etoro logo Buy PACB
*Your capital is at risk
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
MENLO PARK, Calif., May 06, 2020 -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2020. As.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5) • Adverum Biotechnologies...
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
KUALA LUMPUR - Malaysia's Transport Minister Wee Ka Siong on Saturday (May 2) announced that the bilateral agreement deadline for the Johor Baru-Singapore Rapid Transit System (RTS) Link project has b
Illumina (ILMN) exhibits robust growth in the first quarter of 2020 fueled by strong performance of the sequencing consumable subsegment despite the coronavirus pandemic.
Stryker's (SYK) first-quarter earnings gain from strong performance at MedSurg and Neurotechnology and Spine units.
Q1 2020 Illumina Inc Earnings Call
Final earnings conference call transcript of Illumina Inc - ILMN stock
Surmodics (SRDX) registered growth in one of its core units, Invitro Diagnostics, in Q2.
ABIOMED's (ABMD) flagship Impella saw decline in revenues within United States in Q4.
ABIOMED's (ABMD) flagship Impella saw decline in revenues within United States in Q4.
Baxter's (BAX) first-quarter earnings benefit from solid segmental performance and growth across all geographies.
Baxter's (BAX) first-quarter earnings benefit from solid segmental performance and growth across all geographies.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE